All content on this webpage originated from other webpages,Please check the medicilon's website for details. Medicilon offers fully integrated pharmaceutical services for the global scientific community. We focus on providing an exceptional client-centered experience and advancing the drug discovery process.
Email: Marketing@medicilon.com.cn Website: www.medicilon.com
This case study examines an drug safety evaluation Abuse Resistance Education Program (D.A.R.E.) as it operates in Minnesota, sponsored and published by the Minnesota D.A.R.E. Advisory Council in July of 1997. The study describes the evaluation process and documents uses of the evaluation process, findings, and recommendations. The case study reflects uses of the evaluation that occurred by January 1999, approximately 18 months following the release of the final report. Following Patton's theory of utilization focused evaluation, the study focuses on intended uses by intended users.
Methods employed to conduct the case study include the following: (1) review of the design, process, findings, and recommendations of the 1997 D.A.R.E. program evaluation, (2) review and analysis of public documents from the Minnesota D.A.R.E. Advisory Council, Minnesota D.A.R.E. Inc., and the Minnesota Department of Public Safety, and (3) key informant interviews with representatives of the Minnesota Attorney General's Office responsible for staffing the Minnesota D.A.R.E. Advisory Council, Minnesota D.A.R.E. Inc., and the Minnesota Department of Public Safety.
Evaluation sponsors and other key stakeholders have used the drug safety evaluation to improve staff training, clarify program goals, increase parental involvement, and increase cooperation with other prevention efforts. Factors influencing uses of the evaluation include the context and timing of the evaluation, the visible leadership of the State Attorney General, commitment to use the evaluation by other key program officials, increasing public attention to the program, and intentional involvement of potential users by the evaluation team.